Mouth and Oropharyngeal Deposition of Pharmaceutical Aerosols
- 1 June 1998
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Aerosol Medicine
- Vol. 11 (s1) , S116-116
- https://doi.org/10.1089/jam.1998.11.suppl_1.s-116
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Lung Deposition of Salbutamol from the Leiras Metered Dose Powder InhalerJournal of Aerosol Medicine, 1995
- Aerosol Deposition as a Function of Airway Disease: Cystic FibrosisPharmaceutical Research, 1995
- Effect of different modes of inhalation on drug delivery from a dry powder inhalerInternational Journal of Pharmaceutics, 1994
- A comparison of the lung deposition of salbutamol inhaled from a new dry powder inhaler, at two inhaled flow ratesInternational Journal of Pharmaceutics, 1994
- Modelling the deposition of inhaled powdered drug aerosolsJournal of Aerosol Science, 1994
- Total and regional lung deposition of terbutaline sulphate inhaled via a pressurised MDI or via Turbuhaler®International Journal of Pharmaceutics, 1993
- An Empirical Model Describing the Postnatal Growth of Organs in ICRP Reference Humans: I. The LungsRadiation Protection Dosimetry, 1991
- Modelling and algebraic formulation of regional aerosol deposition in manJournal of Aerosol Science, 1990
- Pressurised aerosol deposition in the human lung with and without an "open" spacer device.Thorax, 1989
- Intercomparison of Experimental Regional Aerosol Deposition DataJournal of Aerosol Medicine, 1989